Further results of ELISA showed that the expression IL-17A and TNF-α were upregulated by YYFZBJS treatment, which suggested that YYFZBJS blocked tumor progression in CRC murine model possibly via inhibiting the accumulation of Treg cells in immune organs, and in tumor microenvironment. The gene discussed is IL17A; the disease is neoplasm.